These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32207199)

  • 1. Extracellular Matrix Proteins Involved in Alzheimer's Disease.
    Ma J; Ma C; Li J; Sun Y; Ye F; Liu K; Zhang H
    Chemistry; 2020 Sep; 26(53):12101-12110. PubMed ID: 32207199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant Upregulation of Alzheimer's β-Amyloid Levels in a Living System Induced by Extracellular Elastin Polypeptides.
    Ma C; Su J; Sun Y; Feng Y; Shen N; Li B; Liang Y; Yang X; Wu H; Zhang H; Herrmann A; Tanzi RE; Liu K; Zhang C
    Angew Chem Int Ed Engl; 2019 Dec; 58(51):18703-18709. PubMed ID: 31609093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease.
    Liu CC; Zhao N; Yamaguchi Y; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    Sci Transl Med; 2016 Mar; 8(332):332ra44. PubMed ID: 27030596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate proteoglycan in Alzheimer's disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism.
    Ozsan McMillan I; Li JP; Wang L
    Am J Physiol Cell Physiol; 2023 Apr; 324(4):C893-C909. PubMed ID: 36878848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extracellular matrix enriched with membrane metalloendopeptidase and insulin-degrading enzyme suppresses the deposition of amyloid-beta peptide in Alzheimer's disease cell models.
    Zhang S; Xiao T; Yu Y; Qiao Y; Xu Z; Geng J; Liang Y; Mei Y; Dong Q; Wang B; Wei J; Suo G
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1759-1769. PubMed ID: 31151136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Jean L; Brimijoin S; Vaux DJ
    J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease.
    Zhang GL; Zhang X; Wang XM; Li JP
    Biomed Res Int; 2014; 2014():516028. PubMed ID: 25157361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix modulator lysyl oxidase colocalizes with amyloid-beta pathology in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis--Dutch type.
    Wilhelmus MM; Bol JG; van Duinen SG; Drukarch B
    Exp Gerontol; 2013 Feb; 48(2):109-14. PubMed ID: 23267843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.
    van Horssen J; Wesseling P; van den Heuvel LP; de Waal RM; Verbeek MM
    Lancet Neurol; 2003 Aug; 2(8):482-92. PubMed ID: 12878436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease as oligomeropathy.
    Ono K
    Neurochem Int; 2018 Oct; 119():57-70. PubMed ID: 28821400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
    Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
    Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.